DOCSLIB.ORG

Reelin Modulates Plcγ2 Phosphorylation Upon Platelet

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Reelin Modulates Plcγ2 Phosphorylation Upon Platelet Reelin modulates PLCγ2 phosphorylation upon platelet activation and integrin outside-in signaling Irena Krüger1, Nina Sarah Gowert1, Meike Klier1, Hans H. Bock2, Margitta Elvers1 1Clinic for Vascular and Endovascular Surgery, Heinrich Heine University Medical Center, Düsseldorf, Germany 2Clinic for Gastroenterology, Hepatology and Infectiology, Heinrich Heine University Medical Center, Düsseldorf, Germany Aim of the Project Methods Reelin is known as an extracellular matrix protein which is produced In vitro and in vivo analysis of Reeler mice. by Cajal-Retzius neurons mediating cell migration in brain development. Recent studies provide evidence that Reelin is expressed in platelets, where it co-localizes to F-Aktin. Moreover, Reelin influences static adhesion on CRP and binding to GPVI Reelin binds to amyloid precursor protein (APP) and apolipoprotein E A B ´ Figure 5: Reelin is receptor 2 (ApoER2) and is important for thrombus formation under wt -JAQ1 high shear suggesting that Reelin is modulating glycoprotein (GP)Ib influencing adhesion on *** CRP and binding onto 350 *** 200 GPVI. (A) Wildtype and signaling in platelets. Consequently, defective thrombus formation 180 300 Reeler platelets were allowed protects Reelin-deficient mice (Reeler) against arterial thrombosis. 160 250 140 to adhere for 20 min onto a 120 This prompted to analyze the role and signaling mechanisms of 200 CRP matrix (1µg/ml), n=5. 100 reeler +JAQ1 (B) Resting wildtype platelets Reelin in platelet cytoskeletal reorganization, activation and 150 80 rest +Jaq1 -JAQ1 60 and with GPVI antibody 100 aggregation. 40 (JAQ1) treated wildtype cells cells per visual field cells cells per visual field 50 20 platelets were allowed to 0 0 adhere onto a Reelin matrix. wt reeler -JAQ1 +JAQ1 Reelin is present in platelets and released upon activation Bar graphs depict mean ± sem, *** P< 0.001. A B C Reelin 250 lysat rest supernatant 200 Reelin is influencing Integrin αIIbβIIIoutside-in signaling 150 F-Actin A 90 ** 80 100 ´ [pg/ml] +CRP 70 wt 6 min reeler wt 120 min reeler Volume 60 50 50 Mouse Reelin concentrationReelin Mouse merge 40 % % starting 30 0 20 wt 300 min reeler Thrombin Thrombin CRP CRP rest 10 10 min 60 min 10 min 60 min 0 wt 60 min reeler wt 300 min reeler Figure 1: Reelin is a platelet protein. (A) Reelin concentrations in the supernatant and lysates of platelets stimulated with thrombin (0.2 U/ml) and CRP (10 µg/ml) , respectively for 10 and 60 minutes were measured at indicated time points by sandwich ELISA assay. Rest = Figure 6: Reeler PRP shows impaired clot retraction thus Reelin enhances Integrin αIIbβIIIoutside-in signaling. (A) PRP from wt (black) resting platelets without stimulation, bar graphs depict mean values ± sem, n=3. (B) Platelets were isolated and stimulated with CRP (10 and reeler mice (grey) was stimulated with thrombin (5 U/ml) in the presence of CaCl2 (20mM) and photographed after several time points (0, µg/ml). Antibody: Anti-Reelin G10. (C) Reelin is present in platelets and co-localizes to F-actin. Platelets were washed and allowed to 60, 120 and 300 minutes). After 300 minutes the supernatant fluid was removed and its volume was measured and compared against the spread on immobilized human fibrinogen (100 µg/ml) for 60 min, fixed and stained for Reelin (clone G10, red) and for F-actin (Rhodamin- starting volume. Bar graphs depict mean values ± sem, n = 5-6, ** P ˂ 0.01. Phalloidin). Scale bar 10 µm. Reeler platelets show reduced activation upon GPVI stimulation Reeler mice are protected against arterial thrombosis * Figure 7: Reduced platelet A B Figure 2: Rl-/- are protected against * activation upon Reelin arterial thrombosis without affecting ** deficiency. (A) Blood was 1200 rl+/+ after 40 min bleeding time. (A) After injury of washed twice and incubated mesenteric arterioles with 20% FeCl , with 0.002, 0.02 and 0.1 U/ml 1000 3 platelet adhesion and thrombus thrombin; 1, 5 and 10 µg/ml 800 formation were monitored in vivo by CRP; 10 µM ADP; 10/3 µM fluorescence microscopy. Percent ´ ADP/U46 and 75, 100 µM 600 A rl-/- after 40 min distribution of irreversible occlusion PAR-4 as indicated for 15 ´ 400 (black), instable occlusion (dark grey) minutes in the presence of anti- Tail bleeding time (s) bleedingTail and no occlusion (light grey). Shear rate P-selectin and JON/A-PE 200 1.300 sec-1 (n=5). (B) Tail bleeding times antibodies. Platelets were +/+ -/- 0 for Rl and Rl mice. Each symbol gated by their forward and rl+/+ rl-/- represents one animal (n=15-17). (C) sideward characteristics. The *** Wildtype mice were injected with CR-50 ** mean fluorescence intensity *** C (20 µg/mice) and IgG (20 µg/mice) as (MFI) for each measurement is control. After injection of DCF the shown (n= 5). * P< 0,05, **P< mesenteric arterioles were injured with 0,01, ***P< 0,001. 20 % FeCl3 and thrombus formation was 0.002 0.02 0.1 1 5 10 10 10/3 75 100 monitored by fluorescence microscopy. Thrombin CRP ADP/U46 PAR-4 Representative pictures (left panel) and rest [U/ml] [µg/ml] ADP [µM] [µM] time to irreversible occlusion (right panel) was determined. Each symbol represents one individual mouse, n=3. Reelin modulates PLCγ2 phosphorylation A Reelin induces phosphorylation of the Rac1/Cdc42 effector PAK WT reeler A wt - p-PLCg2 CRP rest Reelin - PLCg2 1´ 2´ 1´ 5´ 15´ PAK- - p-Syk - Syk p-PAK- d ´ modified according to Bigalke et al., Current Drug Targets, 2011 - β-Tubulin b-tubulin- rest CRP rest CRP Figure 8: Intracellular Reelin is modulating PLCγ2 phosphorylation upon GPVI stimulation. (A) Wildtype platelets were stimulated Figure 3: Reelin is important for phosphorylation of Rho target Protein PAK1/2. (A) Wildtype platelets were stimulated with with CRP (5µg/ml) for 2 minutes, lysed and western blots were performed against phosphorylated PLCγ2 and PLCγ2 and CRP (10µg/ml) for 1 and 2 minutes and with recombinant Reelin (1:10) for 1, 5 and 15 minutes, lysed and western blots were Aslan et al., American Journal of Physiology, 2013 phosphorylated Syk and Syk. β-Tubulin was serving as loading control (n=4). performed against phosphorylated PAK and PAK. β-Tubulin was serving as loading control (n=3). Reelin supports lamellipodia formation on fibrinogen Conclusion A B 20 min wt reeler wt reeler Taken together these data provide first evidence for Reelin mediating signaling through GPVI and 100 90 modulating outside-in signaling suggesting that Reelin is a modulator for PLCγ2 phosphorylation in 80 lamellipodia 70 % platelets. 60 50 Our study reveals an important role for Reelin in hemostasis and arterial thrombosis, thus being a filopodia 40 Cell count in 30 promising therapeutic target for antithrombotic therapy. 20 adherent 10 cells 0 + thr + rec. Rln + thr/rec.Rln References 60 min 100 no treatment + thrombin 90 (1) Tseng WL, Huang CL, Chong KY, Liao CH, Stern A, Cheng JC, Tseng CP. Reelin is a platelet protein and functions as a positive 80 regulator of platelet spreading on fibrinogen. Cell Mol Life Sci. 2010 Feb;67(4):641-53. 70 in % 60 (2) Tseng WL, Chen TH, Huang CC, Huang YH, Yeh CF, Tsai HJ, Lee HY, Kao CY, Lin SW, Liao HR, Cheng JC, Tseng CP. Impaired 50 thrombin generation in Reelin-deficient mice: a potential role of plasma Reelin in hemostasis. Thromb Haemost. 2014 40 Dec;12(12):2054-64. Cell count 30 20 (3) Leemhuis J, Bouché, E, Frotscher, M, Henle, F, Hein, L, Herz, J, Meyer, DK, Pichler, M, Roth, G, Schwan, C, Bock, HH. Reelin 10 0 signals through Apoer2 and Cdc42 to increase growth cone motility and filopodia formation. J Neurosci. 2010 Nov; 30 (44):14759- + thr +rec. Rln + thr/rec.Rln 14772. (4) D'Arcangelo G, Nakajima K, Miyata T, Ogawa M, Mikoshiba K, Curran T. Reelin is a secreted glycoprotein recognized by the CR- Figure 4: Reelin is supporting lamellipodia formation. (A) Wildtype platelets were allowed to adhere on immobilized human fibrinogen 50 monoclonal antibody. The Journal of neuroscience : the official journal of the Society for Neuroscience. 1997;17(1):23-31. (1 mg/ml) without stimulation and stimulated with thrombin and recombinant Reelin. Graph bars depictmodified meanaccording to Goggsvalues, Williams etafter al., Biochemical20 Journal,and 201560 (5) 1. Archangelo GD, Miao GG, Chen S-C, Soares HD, Morgan JI, Curran T. A Protein Related to Extracellular-Matrix Proteins minutes, n=3-5. (B) Wildtype and Reeler platelets were allowed to spread on fibrinogen (1 mg/ml) and compared to spreaded wildtype and Deleted in the Mouse Mutant Reeler. Nature. 1995;374:719-23. Reeler platelets with thrombin stimulation (0.008U/ml). Bar graphs depict mean values ± s.e.m. after 20 and 60 min, n = 3-5. * P< 0.05. Disclosure Statement of Financial Interest Acknowledgments I, Irena Krüger, DO NOT have a financial interest/arrangement or affiliation with one or more organizations that could be We thank Martina Spelleken for providing outstanding technical assistance. perceived as a real or apparent conflict of interest in the context of the subject of this presentation. 1334--PB Platelet Signaling Poster presented at ISTH2017 on: 2017 Irena Krger DOI: 10.3252/pso.eu.ISTH2017.2017 Tuesday, July 11 ISTH.
Load more

Recommended publications
  • MONONINE (“Difficulty ® Monoclonal Antibody Purified in Concentrating”; Subject Recovered)
    CSL Behring IU/kg (n=38), 0.98 ± 0.45 K at doses >95-115 IU/kg (n=21), 0.70 ± 0.38 K at doses >115-135 IU/kg (n=2), 0.67 K at doses >135-155 IU/kg (n=1), and 0.73 ± 0.34 K at doses >155 IU/kg (n=5). Among the 36 subjects who received these high doses, only one (2.8%) Coagulation Factor IX (Human) reported an adverse experience with a possible relationship to MONONINE (“difficulty ® Monoclonal Antibody Purified in concentrating”; subject recovered). In no subjects were thrombo genic complications MONONINE observed or reported.4 only The manufacturing procedure for MONONINE includes multiple processing steps that DESCRIPTION have been designed to reduce the risk of virus transmission. Validation studies of the Coagulation Factor IX (Human), MONONINE® is a sterile, stable, lyophilized concentrate monoclonal antibody (MAb) immunoaffinity chromatography/chemical treatment step and of Factor IX prepared from pooled human plasma and is intended for use in therapy nanofiltration step used in the production of MONONINE doc ument the virus reduction of Factor IX deficiency, known as Hemophilia B or Christmas disease. MONONINE is capacity of the processes employed. These studies were conducted using the rel evant purified of extraneous plasma-derived proteins, including Factors II, VII and X, by use of enveloped and non-enveloped viruses. The results of these virus validation studies utilizing immunoaffinity chromatography. A murine monoclonal antibody to Factor IX is used as an a wide range of viruses with different physicochemical properties are summarized in Table affinity ligand to isolate Factor IX from the source material.
    [Show full text]
  • Reelin Is Preferentially Expressed in Neurons Synthesizing ␥-Aminobutyric Acid in Cortex and Hippocampus of Adult Rats
    Proc. Natl. Acad. Sci. USA Vol. 95, pp. 3221–3226, March 1998 Neurobiology Reelin is preferentially expressed in neurons synthesizing g-aminobutyric acid in cortex and hippocampus of adult rats C. PESOLD*†,F.IMPAGNATIELLO*, M. G. PISU*, D. P. UZUNOV*, E. COSTA*, A. GUIDOTTI*, AND H. J. CARUNCHO*‡ *Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612; and ‡Department of Morphological Sciences, University of Santiango de Compostela School of Medicine, 15705 Santiago de Compostela, Spain Contributed by Erminio Costa, December 24,1997 ABSTRACT During embryonic development of brain lam- sion, prevent Reelin transcription or secretion (4, 12, 14). In inated structures, the protein Reelin, secreted into the extracel- the cortex and hippocampus of rat embryos, Reelin begins to lular matrix of the cortex and hippocampus by Cajal–Retzius be synthesized in Cajal–Retzius (CR) cells from embryonic day (CR) cells located in the marginal zone, contributes to the 13 to the second postnatal week, and in the cerebellum Reelin regulation of migration and positioning of cortical and hip- is expressed first in the external granule cell layer (EGL) pocampal neurons that do not synthesize Reelin. Soon after before the granule cell migration to the internal granule cell birth, the CR cells decrease, and they virtually disappear during layer (IGL) (2, 15–17). When the CR50 antibody is added to the following 3 weeks. Despite their disappearance, we can embryonic preparations expressing normal histogenetic pat- quantify Reelin mRNA (approximately 200 amolymg of total terns of lamination, it induces typical histogenetic abnormal- RNA) and visualize it by in situ hybridization, and we detect the ities of the Relnrl phenotype (7, 9, 10, 17).
    [Show full text]
  • Reelin Supplementation Into the Hippocampus Rescues Abnormal Behavior in a Mouse Model of Neurodevelopmental Disorders
    fncel-14-00285 August 31, 2020 Time: 14:32 # 1 ORIGINAL RESEARCH published: 02 September 2020 doi: 10.3389/fncel.2020.00285 Reelin Supplementation Into the Hippocampus Rescues Abnormal Behavior in a Mouse Model of Neurodevelopmental Disorders Daisuke Ibi1*†, Genki Nakasai1†, Nayu Koide1†, Masahito Sawahata2, Takao Kohno3, Rika Takaba1, Taku Nagai2,4, Mitsuharu Hattori3, Toshitaka Nabeshima5, Kiyofumi Yamada2* and Masayuki Hiramatsu1 1 Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan, 2 Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Japan, 3 Department of Biomedical Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan, 4 Project Office for Neuropsychological Research Center, Fujita Health University, Toyoake, Japan, 5 Advanced Diagnostic System Research Laboratory, Fujita Health University, Graduate School of Health Sciences, Toyoake, Japan Edited by: Marie-Eve Tremblay, In the majority of schizophrenia patients, chronic atypical antipsychotic administration University of Victoria, Canada produces a significant reduction in or even complete remission of psychotic symptoms Reviewed by: such as hallucinations and delusions. However, these drugs are not effective in Dilja Krueger-Burg, improving cognitive and emotional deficits in patients with schizophrenia. Atypical University Medical Center Göttingen, Germany antipsychotic drugs have a high affinity for the dopamine D2 receptor, and a José M. Delgado-García,
    [Show full text]
  • Clinical Study High Complement Factor I Activity in the Plasma of Children with Autism Spectrum Disorders
    Hindawi Publishing Corporation Autism Research and Treatment Volume 2012, Article ID 868576, 6 pages doi:10.1155/2012/868576 Clinical Study High Complement Factor I Activity in the Plasma of Children with Autism Spectrum Disorders Naghi Momeni,1 Lars Brudin,2 Fatemeh Behnia,3 Berit Nordstrom,¨ 4 Ali Yosefi-Oudarji,5 Bengt Sivberg,4 Mohammad T. Joghataei,5 and Bengt L. Persson1 1 School of Natural Sciences, Linnaeus University, 39182 Kalmar, Sweden 2 Department of Clinical Physiology, Kalmar County Hospital, 39185 Kalmar, Sweden 3 Department of Occupational Therapy, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran 4 Department of Health Sciences, Autism Research, Faculty of Medicine, Lund University, Box 157, 22100 Lund, Sweden 5 Cellular and Molecular Research Centre, Tehran University of Medical Sciences (TUMS), Tehran, Iran Correspondence should be addressed to Bengt Sivberg, [email protected] Received 17 June 2011; Revised 22 August 2011; Accepted 22 August 2011 Academic Editor: Judy Van de Water Copyright © 2012 Naghi Momeni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Autism spectrum disorders (ASDs) are neurodevelopmental and behavioural syndromes affecting social orientation, behaviour, and communication that can be classified as developmental disorders. ASD is also associated with immune system abnormality. Im- mune system abnormalities may be caused partly by complement system factor I deficiency. Complement factor I is a serine pro- tease present in human plasma that is involved in the degradation of complement protein C3b, which is a major opsonin of the complement system.
    [Show full text]
  • Coagulation Factors Directly Cleave SARS-Cov-2 Spike and Enhance Viral Entry
    bioRxiv preprint doi: https://doi.org/10.1101/2021.03.31.437960; this version posted April 1, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry. Edward R. Kastenhuber1, Javier A. Jaimes2, Jared L. Johnson1, Marisa Mercadante1, Frauke Muecksch3, Yiska Weisblum3, Yaron Bram4, Robert E. Schwartz4,5, Gary R. Whittaker2 and Lewis C. Cantley1,* Affiliations 1. Meyer Cancer Center, Department of Medicine, Weill Cornell Medical College, New York, NY, USA. 2. Department of Microbiology and Immunology, Cornell University, Ithaca, New York, USA. 3. Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA. 4. Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA. 5. Department of Physiology, Biophysics and Systems Biology, Weill Cornell Medicine, New York, NY, USA. *Correspondence: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2021.03.31.437960; this version posted April 1, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Summary Coagulopathy is recognized as a significant aspect of morbidity in COVID-19 patients. The clotting cascade is propagated by a series of proteases, including factor Xa and thrombin. Other host proteases, including TMPRSS2, are recognized to be important for cleavage activation of SARS-CoV-2 spike to promote viral entry. Using biochemical and cell-based assays, we demonstrate that factor Xa and thrombin can also directly cleave SARS-CoV-2 spike, enhancing viral entry.
    [Show full text]
  • Thrombin-Jmi
    THROMBIN-JMI - thrombin, topical (bovine) THROMBIN-JMI; THROMBIN-JMI PUMP SPRAY KIT; THROMBIN-JMI SYRINGE SPRAY KIT - thrombin, topical (bovine) THROMBIN-JMI SYRINGE SPRAY KIT - thrombin, topical (bovine) THROMBIN-JMI EPISTAXIS KIT - thrombin, topical (bovine) King Pharmaceuticals, Inc. ---------- THROMBIN, TOPICAL U.S.P. (BOVINE ORIGIN) THROMBIN-JMI® Thrombin, Topical (Bovine) must not be injected! Apply on the surface of bleeding tissue. DESCRIPTION The thrombin in Thrombin, Topical (Bovine Origin) THROMBIN-JMI® is a protein substance produced through a conversion reaction in which prothrombin of bovine origin is activated by tissue thromboplastin of bovine origin in the presence of calcium chloride. It is supplied as a sterile powder that has been freeze-dried in the final container. Also contained in the preparation are mannitol and sodium chloride. Mannitol is included to make the dried product friable and more readily soluble. The material contains no preservative. THROMBIN-JMI® has been chromatographically purified and further processed by ultrafiltration. Analytical studies demonstrate the current manufacturing process’ capability to remove significant amounts of extraneous proteins, and result in a reduction of Factor Va light chain content to levels below the limit of detection of semi-quantitative Western Blot assay (<92 ng/mL, when reconstituted as directed). The clinical significance of these findings is unknown. CLINICAL PHARMACOLOGY THROMBIN-JMI® requires no intermediate physiological agent for its action. It clots the fibrinogen of the blood directly. Failure to clot blood occurs in the rare case where the primary clotting defect is the absence of fibrinogen itself. The speed with which thrombin clots blood is dependent upon the concentration of both thrombin and fibrinogen.
    [Show full text]
  • Reelin Gene Polymorphisms in Autistic Disorder
    Chapter 25 Reelin Gene Polymorphisms in Autistic Disorder Carla Lintas and Antonio Maria Persico Contents 1 Introduction ....................................................................................................................... 385 2 RELN Gene Polymorphisms and Autism .......................................................................... 386 3 Functional Studies of RELN GGC Alleles ........................................................................ 389 4 RELN GGC Alleles and Autism: Replication Studies ....................................................... 390 5 Modeling RELN Gene Contributions to Autism: The Challenge of Complexity .............. 394 References ............................................................................................................................... 396 1 Introduction Migratory streams occur throughout the central nervous system (CNS) during devel- opment. Neuronal and glial cell populations migrate out of proliferative zones to reach their final location, where neurons soon establish early intercellular connec- tions. Reelin plays a pivotal role in cell migration processes, acting as a stop signal for migrating neurons in several CNS districts, including the neocortex, the cerebel- lum, and the hindbrain (Rice and Curran, 2001). At the cellular level, Reelin acts by binding to a variety of receptors, including the VLDL receptors, ApoER2, and α3β1 integrins, and also by exerting a proteolytic activity on extracellular matrix proteins, which is critical to neuronal migration
    [Show full text]
  • Reelin, a Marker of Stress Resilience in Depression and Psychosis
    Neuropsychopharmacology (2011) 36, 2371–2372 & 2011 American College of Neuropsychopharmacology. All rights reserved 0893-133X/11 www.neuropsychopharmacology.org Commentary Reelin, a Marker of Stress Resilience in Depression and Psychosis ,1,2 S Hossein Fatemi* 1 2 Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA; Departments of Neuroscience and Pharmacology, University of Minnesota Medical School, Minneapolis, MN, USA Neuropsychopharmacology (2011) 36, 2371–2372; doi:10.1038/npp.2011.169 Reelin protein is an extracellular matrix protease respon- common phenomena subserving cognitive deficits in multi- sible for normal lamination of the brain during embryo- ple disorders including lissencephaly, Alzheimer’s disease, genesis, and is involved in cell signaling and synaptic and temporal lobe epilepsy. The causative factors may plasticity in adult life. The Reelin gene (RELN) is localized include a mutation in the RELN gene (lissencephaly) to to chromosome 7 in humans and chromosome 5 in mice, variable expression of the molecule due to hypermethylation and produces a protein product with relative molecular of the promoter region of the RELN gene or other unknown mass of 388 kDa. Reelin protein is localized to a number of mechanisms. Moreover, several non-CNS disorders have brain sites, specifically Cajal–Retzius cells located in layer 1 been associated with changes in expression of Reelin of neocortex, GABAergic interneurons, and cerebellar including several forms of cancers and otosclerosis. granule cells. Activation of the Reelin signaling pathway In the current issue, Teixeira and colleagues evaluated the leads to various, important functions such as enhancement effects of overexpression of Reelin in a transgenic mouse of long-term potentiation, cell proliferation, cell migration, model as compared with wild-type mice and to hetero- and more importantly dendritic spine morphogenesis.
    [Show full text]
  • Plasminogen Activator Inhibitor 1 Functions As a Urokinase Response Modifier at the Level of Cell Signaling and Thereby Promotes MCF-7 Cell Growth Donna J
    Plasminogen Activator Inhibitor 1 Functions as a Urokinase Response Modifier at the Level of Cell Signaling and Thereby Promotes MCF-7 Cell Growth Donna J. Webb, Keena S. Thomas, and Steven L. Gonias Department of Pathology, and Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia 22908 Abstract. Plasminogen activator inhibitor 1 (PAI-1) is association of Sos with Shc, whereas uPA caused tran- Downloaded from http://rupress.org/jcb/article-pdf/152/4/741/1297334/0011017.pdf by guest on 28 September 2021 a major inhibitor of urokinase-type plasminogen activa- sient association of Sos with Shc. tor (uPA). In this study, we explored the role of PAI-1 By sustaining ERK phosphorylation, PAI-1 con- in cell signaling. In MCF-7 cells, PAI-1 did not directly verted uPA into an MCF-7 cell mitogen. This activity activate the mitogen-activated protein (MAP) kinases, was blocked by receptor-associated protein and not ob- extracellular signal–regulated kinase (ERK) 1 and served with uPA–PAI-1R76E complex, demonstrating ERK2, but instead altered the response to uPA so the importance of the VLDLr. uPA promoted the that ERK phosphorylation was sustained. This effect growth of other cells in which ERK phosphorylation required the cooperative function of uPAR and the was sustained, including ␤3 integrin overexpressing very low density lipoprotein receptor (VLDLr). When MCF-7 cells and HT 1080 cells. The MEK inhibitor, MCF-7 cells were treated with uPA–PAI-1 complex in PD098059, blocked the growth-promoting activity of the presence of the VLDLr antagonist, receptor-associ- uPA and uPA–PAI-1 complex in these cells.
    [Show full text]
  • Protein C Product Monograph 1995 COAMATIC® Protein C Protein C
    Protein C Product Monograph 1995 COAMATIC® Protein C Protein C Protein C, Product Monograph 1995 Frank Axelsson, Product Information Manager Copyright © 1995 Chromogenix AB. Version 1.1 Taljegårdsgatan 3, S-431 53 Mölndal, Sweden. Tel: +46 31 706 20 00, Fax: +46 31 86 46 26, E-mail: [email protected], Internet: www.chromogenix.se COAMATIC® Protein C Protein C Contents Page Preface 2 Introduction 4 Determination of protein C activity with 4 snake venom and S-2366 Biochemistry 6 Protein C biochemistry 6 Clinical Aspects 10 Protein C deficiency 10 Assay Methods 13 Protein C assays 13 Laboratory aspects 16 Products 17 Diagnostic kits from Chromogenix 17 General assay procedure 18 COAMATIC® Protein C 19 References 20 Glossary 23 3 Protein C, version 1.1 Preface The blood coagulation system is carefully controlled in vivo by several anticoagulant mechanisms, which ensure that clot propagation does not lead to occlusion of the vasculature. The protein C pathway is one of these anticoagulant systems. During the last few years it has been found that inherited defects of the protein C system are underlying risk factors in a majority of cases with familial thrombophilia. The factor V gene mutation recently identified in conjunction with APC resistance is such a defect which, in combination with protein C deficiency, increases the thrombosis risk considerably. The Chromogenix Monographs [Protein C and APC-resistance] give a didactic and illustrated picture of the protein C environment by presenting a general view of medical as well as technical matters. They serve as an excellent introduction and survey to everyone who wishes to learn quickly about this field of medicine.
    [Show full text]
  • EXPERT COMMITTEE on BIOLOGICAL STANDARDIZATION Geneva, 17 to 21 October 2016
    WHO/BS/2016.2282 ENGLISH ONLY EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION Geneva, 17 to 21 October 2016 An international collaborative study to calibrate the WHO 2nd International Standard for Ancrod (15/106) and the WHO Reference Reagent for Batroxobin (15/140) Craig Thelwell1ᶲ, Colin Longstaff1ᶿ, Peter Rigsby2, Matthew Locke1 and Sally Bevan1 1Biotherapeutics Group, Haemostasis Section and 2Biostatistics Section, National Institute for Biological Standards and Control, South Mimms, Herts EN6 3QG, UK ᶲProject leader for Ancrod; ᶿProject leader for Batroxobin NOTE: This document has been prepared for the purpose of inviting comments and suggestions on the proposals contained therein, which will then be considered by the Expert Committee on Biological Standardization (ECBS). Comments MUST be received by 16 September 2016 and should be addressed to the World Health Organization, 1211 Geneva 27, Switzerland, attention: Technologies, Standards and Norms (TSN). Comments may also be submitted electronically to the Responsible Officer: Dr C M Nübling at email: [email protected] © World Health Organization 2016 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press through the WHO web site: (http://www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
    [Show full text]
  • Role for Reelin in the Development of Granule Cell Dispersion in Temporal Lobe Epilepsy
    The Journal of Neuroscience, July 15, 2002, 22(14):5797–5802 Brief Communication Role for Reelin in the Development of Granule Cell Dispersion in Temporal Lobe Epilepsy Carola A. Haas,1 Oliver Dudeck,2 Matthias Kirsch,1 Csaba Huszka,1 Gunda Kann,1 Stefan Pollak,3 Josef Zentner,2 and Michael Frotscher1 1Institute of Anatomy, 2Department of Neurosurgery, and 3Institute of Forensic Medicine, University of Freiburg, D-79001 Freiburg, Germany The reelin signaling pathway plays a crucial role during the lobe epilepsy. These results suggest that reelin is required for development of laminated structures in the mammalian brain. normal neuronal lamination in humans, and that deficient reelin Reelin, which is synthesized and secreted by Cajal–Retzius expression may be involved in migration defects associated cells in the marginal zone of the neocortex and hippocampus, is with temporal lobe epilepsy. proposed to act as a stop signal for migrating neurons. Here we show that a decreased expression of reelin mRNA by hip- Key words: human hippocampus; extracellular matrix; neuro- pocampal Cajal–Retzius cells correlates with the extent of mi- nal migration disorder; Cajal–Retzius cells; dentate gyrus; Am- gration defects in the dentate gyrus of patients with temporal mon’s horn sclerosis Newborn forebrain neurons migrate from their site of origin to reelin pathway underlie neuronal migration defects in reeler mu- their definitive positions in the cortical plate. Defects in neuronal tants and in humans with TLE. migration are often associated with epileptic disorders (Palmini et To this end, we have studied the expression of reelin, VLDLR, al., 1991). Temporal lobe epilepsy (TLE), one of the most com- ApoER2, and dab1 in tissue samples of hippocampus removed mon neurological disorders in humans (Margerison and Corsellis, from TLE patients for therapeutic reasons.
    [Show full text]